Cargando…
Human rotavirus VP4 and VP7 genetic diversity and detection of GII norovirus in Ibadan as Nigeria introduces rotavirus vaccine
OBJECTIVE: This cross-sectional study investigated the circulating strains of rotavirus and screened for noravirus in Ibadan, Nigeria as the country introduces the rotavirus vaccine into its national immunization program. METHODS: Sixty-five stool samples were collected from children younger than 5...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511342/ https://www.ncbi.nlm.nih.gov/pubmed/36138570 http://dx.doi.org/10.1177/03000605221121956 |
_version_ | 1784797631789137920 |
---|---|
author | Maina, Meshach Maunta Faneye, Adedayo Omotayo Motayo, Babatunde Olanrewaju Nseabasi-Maina, Ntung Adeniji, Adekunle Johnson |
author_facet | Maina, Meshach Maunta Faneye, Adedayo Omotayo Motayo, Babatunde Olanrewaju Nseabasi-Maina, Ntung Adeniji, Adekunle Johnson |
author_sort | Maina, Meshach Maunta |
collection | PubMed |
description | OBJECTIVE: This cross-sectional study investigated the circulating strains of rotavirus and screened for noravirus in Ibadan, Nigeria as the country introduces the rotavirus vaccine into its national immunization program. METHODS: Sixty-five stool samples were collected from children younger than 5 years with clinically diagnosed diarrhea and screened for the presence of rotavirus and norovirus using RT-PCR. Rotavirus-positive samples were further analyzed to determine the G and P genotypes using semi-nested multiplex PCR. RESULTS: The rates of rotavirus and norovirus positivity were 30.8% and 10.8%, respectively, whereas the rate of rotavirus and norovirus mixed infection was 4.6%. G1 was the predominant VP7 genotype, followed by G2, G9, and G1G2G9, whereas the predominant VP4 genotype was P[4], followed by P[6], P[8], and P[9]. The mixed P types P[4]P[8] and P[4]P[6] were also detected. G1P[4] was the most common VP4 and VP7 combination, followed by G2P[4], G1[P6], G1P[8], G2P[6], G2P[9], G9P[6], G2G9P[4], G2P[4]P[6], G1P[4]P[8], G2G9P[8], G1G2G9P[8], and G1[non-typable] P[non-typable], which were detected in at least 5% of the samples. Four samples had a combination of non-typable G and P types. CONCLUSIONS: It is essential to monitor the circulation of virus strains prior to and during the implementation of the immunization program. |
format | Online Article Text |
id | pubmed-9511342 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-95113422022-09-27 Human rotavirus VP4 and VP7 genetic diversity and detection of GII norovirus in Ibadan as Nigeria introduces rotavirus vaccine Maina, Meshach Maunta Faneye, Adedayo Omotayo Motayo, Babatunde Olanrewaju Nseabasi-Maina, Ntung Adeniji, Adekunle Johnson J Int Med Res Prospective Clinical Research Report OBJECTIVE: This cross-sectional study investigated the circulating strains of rotavirus and screened for noravirus in Ibadan, Nigeria as the country introduces the rotavirus vaccine into its national immunization program. METHODS: Sixty-five stool samples were collected from children younger than 5 years with clinically diagnosed diarrhea and screened for the presence of rotavirus and norovirus using RT-PCR. Rotavirus-positive samples were further analyzed to determine the G and P genotypes using semi-nested multiplex PCR. RESULTS: The rates of rotavirus and norovirus positivity were 30.8% and 10.8%, respectively, whereas the rate of rotavirus and norovirus mixed infection was 4.6%. G1 was the predominant VP7 genotype, followed by G2, G9, and G1G2G9, whereas the predominant VP4 genotype was P[4], followed by P[6], P[8], and P[9]. The mixed P types P[4]P[8] and P[4]P[6] were also detected. G1P[4] was the most common VP4 and VP7 combination, followed by G2P[4], G1[P6], G1P[8], G2P[6], G2P[9], G9P[6], G2G9P[4], G2P[4]P[6], G1P[4]P[8], G2G9P[8], G1G2G9P[8], and G1[non-typable] P[non-typable], which were detected in at least 5% of the samples. Four samples had a combination of non-typable G and P types. CONCLUSIONS: It is essential to monitor the circulation of virus strains prior to and during the implementation of the immunization program. SAGE Publications 2022-09-22 /pmc/articles/PMC9511342/ /pubmed/36138570 http://dx.doi.org/10.1177/03000605221121956 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Prospective Clinical Research Report Maina, Meshach Maunta Faneye, Adedayo Omotayo Motayo, Babatunde Olanrewaju Nseabasi-Maina, Ntung Adeniji, Adekunle Johnson Human rotavirus VP4 and VP7 genetic diversity and detection of GII norovirus in Ibadan as Nigeria introduces rotavirus vaccine |
title | Human rotavirus VP4 and VP7 genetic diversity and detection of GII norovirus in Ibadan as Nigeria introduces rotavirus vaccine |
title_full | Human rotavirus VP4 and VP7 genetic diversity and detection of GII norovirus in Ibadan as Nigeria introduces rotavirus vaccine |
title_fullStr | Human rotavirus VP4 and VP7 genetic diversity and detection of GII norovirus in Ibadan as Nigeria introduces rotavirus vaccine |
title_full_unstemmed | Human rotavirus VP4 and VP7 genetic diversity and detection of GII norovirus in Ibadan as Nigeria introduces rotavirus vaccine |
title_short | Human rotavirus VP4 and VP7 genetic diversity and detection of GII norovirus in Ibadan as Nigeria introduces rotavirus vaccine |
title_sort | human rotavirus vp4 and vp7 genetic diversity and detection of gii norovirus in ibadan as nigeria introduces rotavirus vaccine |
topic | Prospective Clinical Research Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511342/ https://www.ncbi.nlm.nih.gov/pubmed/36138570 http://dx.doi.org/10.1177/03000605221121956 |
work_keys_str_mv | AT mainameshachmaunta humanrotavirusvp4andvp7geneticdiversityanddetectionofgiinorovirusinibadanasnigeriaintroducesrotavirusvaccine AT faneyeadedayoomotayo humanrotavirusvp4andvp7geneticdiversityanddetectionofgiinorovirusinibadanasnigeriaintroducesrotavirusvaccine AT motayobabatundeolanrewaju humanrotavirusvp4andvp7geneticdiversityanddetectionofgiinorovirusinibadanasnigeriaintroducesrotavirusvaccine AT nseabasimainantung humanrotavirusvp4andvp7geneticdiversityanddetectionofgiinorovirusinibadanasnigeriaintroducesrotavirusvaccine AT adenijiadekunlejohnson humanrotavirusvp4andvp7geneticdiversityanddetectionofgiinorovirusinibadanasnigeriaintroducesrotavirusvaccine |